TAK TAKEDA PHARMACEUTICAL CO LTD: institutional ownership and insider trading
421 funds reported holding $1.73B of TAKEDA PHARMACEUTICAL CO LTD in their latest 13F filings; in Q2 2026 funds net bought $99.4M, with 62 new positions and 40 funds selling out; over the last 12 months insiders bought $0 and sold $13.1M on the open market.
Famous investors holding TAK
- Renaissance Technologies (Renaissance Technologies): $41.2M, 0.1% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $32.9M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $16.8M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $7.79M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $14.9M, 0.0% of the portfolio
Largest institutional holders of TAK
- Capital Research Global Investors — $309M
- FMR LLC — $154M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $112M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $97.0M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $82.2M
- BRANDES INVESTMENT PARTNERS, LP — $72.8M
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — $59.8M
- BlackRock, Inc. (BLK) — $59.1M
- RENAISSANCE TECHNOLOGIES LLC — $41.2M
- Qube Research & Technologies Ltd — $35.4M
Recent TAK insider trades
- Sep 14, 2026: Duprey Lauren Rusckowski sold 34,535 shares ($640K)
- Sep 2, 2026: Plump Andrew Stewart sold 116,191 shares ($2.15M)
- Aug 19, 2026: Plump Andrew Stewart sold 19,651 shares ($363K)
- Aug 18, 2026: Greenway Nicola Deidre Petal sold 12,980 shares ($235K)